Contribution of 18-F-FDG PET for detection of head and neck carcinomas with an unknown primary tumor;Apport du TEP scanner au [18F]-FDG dans les adénopathies cervicales primitives

Annales d'Oto-Laryngologie et de Chirurgie Cervico-Faciale

Volumn 123, Issue 1, 2006, Pages 17-25

  Fakhry, N ^a   Jacob, T ^b   Paris, J ^a   Barberet, M ^c   Mundler, O ^b   Giovanni, A ^a   Zanaret, M ^a  

^a Service d'ORL et de Chirurgie Cervico Faciale du Professeur Zanaret   (France)

^b Service de Médecine Nucléaire du Professeur Mundler

^c TIMONE HOSPITAL   (France)

Author keywords

FDG PET; Head and neck; Squamous cell carcinoma; Unknown primary; Upper aero digestive tract

Indexed keywords

EID: 33645763950     PISSN: 0003438X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-438x(06)76634-8     Document Type: Article

References (34)

1. STOECKLI SJ, MOSNA-FIRLEJCZYK K, GOERRES GW. Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography. Eur J Nucl Med Mol Imaging 2003;30:411-6.
2. WANG RC, GOEPFERT H, BARBER AE, et al. Unknown primary squamous cell carcinoma metastatic to the neck. Arch Otolaryngol Head Neck Surg 1990;116:1388-93.
3. LEIPZIG B, WINTER ML, HOKANSON JA. Cervical nodal metastases of unknown origin. Laryngoscope 1981;91:593-8.
4. SCHAPIRA DV, JARRET AR. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma. Arch Intern Med 1995;155:2050-4.
5. ISSING WJ, TALEBAN B, TAUBER S. Diagnosis and management of carcinoma of unknown primary in the head and neck. Eur Arch Otorhinolaryngol 2003;260:436-43.
6. REGELINK G, BROUWER J, DE BREE, et al. Detection of unknown primary tumors and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities. Eur J Nucl Med Mol Imaging 2002;29:1024-30.
7. NORDSTROM DG, TEWFIK HH, LATOURETTE HB. Cervical lymph node metastases from an unknown primary. Int J Radiat Oncol Biol Phys 1979;5:73-6.
8. BOHUSLAVIZKI KH, KLUTMANN S, KROGER S, et al. FDG PET detection of unknown primary tumors. J Nucl Med 2000;41:816-22.
9. HAAS I, HOFFMANN TK, ENGERS R, et al. Diagnostic strategies in cervical carcinoma of an unknown primary (CUP). Eur Arch Otorhinolaryngol 2002;259:325-33.
10. BUGAT R, BATAILLARD A, LESIMPLE T, et al. FNCLCC, CRLCC. Standards, Options and Recommendations for the management of patient with carcinoma of unknown primary site. Bull Cancer 2002;89:869-75.
11. AASSAR OS, FISCHBEIN NJ, CAPUTO GR, et al. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors. Radiology 1999;210:177-81.
12. LESIMPLE T, VOIGT JJ, BATAILLARD A, et al. FNCLCC. Clinical practice guidelines: Standards, Options and Recommendations for the diagnosis of carcinomas of unknown primary site. Bull Cancer 2003;90:1071-96.
13. GRAU C, JOHANSEN LV, JAKOBSEN J, et al. Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck. Radiother Oncol 2000;55:121-9.
14. MUIR C. Cancer of unknown primary site. Cancer 1995;75:353-6.
15. DELGADO-BOLTON RC, FERNANDEZ-PEREZ C, GONZALEZ-MATE A, et al. Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors. J Nucl Med 2003;44:1301-14.
16. RUSTHOVEN KE, KOSHY M, PAULINO AC. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer 2004;101:2641-9.
17. BOURGUET P, et al. SOR. Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in unknown primary neoplasms. Bull Cancer 2003;90:S103-4.
18. SCHECHTER NR, GILLENWATER AM, BYERS RM, et al. Can positron emission tomography improve the quality of care for head-and-neck cancer patients? Int J Radiat Oncol Biol Phys 2001;51:4-9.
19. rd, et al. PET scanning in head and neck oncology: a review. Head Neck 1998;20:208-15.
20. HANASONO MM, KUNDA LD, SEGALL GM, et al. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 1999;109:880-5.
21. BOURGUET P, et al. SOR. Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the upper aerodigestive tract. Bull Cancer 2003;90:S67-79.
22. SCHMID DT, STOECKLI SJ, BANDHAUER F, et al. Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck. Laryngoscope 2003;113:888-91.
23. GOERRES GW, SCHMID DT, BANDHAUER F, et al. Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2004;130:105-9; discussion 120-1.
24. KUNKEL M, FORSTER GJ, REICHERT TE, et al. Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management. Cancer 2003;98:2257-65.
25. JOHANSEN J, EIGTVED A, BUCHWALD C, et al. Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study. Laryngoscope 2002;112:2009-14.
26. FOGARTY GB, PETERS LJ, STEWART J, et al. The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor. Head Neck 2003;25:138-45.
27. RADES D, KUHNEL G, WILDFANG I, et al. Localised disease in cancer from unknown primary (CUP): The value of positron emission tomography (PET) for individual therapeutic management. Ann oncol 2001;12:1605-9.
28. MILLER FR, HUSSEY D, BEERAM M, et al. Positron Emission Tomography in the management of unknown primary head and neck carcinoma. Arch Otolaryngol Head Neck Surg 2005;131:626-9.
29. WONG WL, SAUNDERS M. The impact of FDG PET on the management of occult primary head and neck tumours. Clin Oncol (R Coll Radiol) 2003;15:461-6.
30. BAR-SHALOM R, YEFREMOV N, GURALNIK L, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003;44:1200-9.
31. GUTZEIT A, ANTOCH G, KUHL H, et al. Unknown primary tumors: detection with dual-modality PET/CT-initial experience. Radiology 2005;234:227-34.
32. NANNI C, RUBELLO D, CASTELLUCCI P, et al. Role of (18) F-FDG PET-CT imaging for the detection of an unknown primary tumour: preliminary results in 21 patients. Eur J Nucl Med Mol Imaging 2005;32:589-92.
33. NAKAMOTO Y, TATSUMI M, HAMMOUD D, et al. Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Radiology 2005;234:879-85.
34. JUNGEHULSING M, SCHEIDHAUER K, DAMM M, et al. 2[F]-fluoro-2-deoxy-D- glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg 2000;123:294-301.